Intra-Cellular Therapies Inc. buy Robert W. Baird
Start price
18.04.24
/
50%
€68.50
Target price
18.04.25
€96.53
Performance (%)
-7.30%
Price
18:54
€63.50
Summary
This prediction is currently active. With a performance of -7.30%, the BUY prediction by Robert_W__Baird is trending in the wrong direction. This prediction currently runs until 18.04.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -5.882% | -5.882% |
iShares Core DAX® | -0.145% | -2.221% |
iShares Nasdaq 100 | 1.296% | 9.035% |
iShares Nikkei 225® | 1.282% | 3.119% |
iShares S&P 500 | 0.442% | 5.429% |
Comments by Robert_W__Baird for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Robert W. Baird from $83.00 to $103.00. They now have an "outperform" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Robert_W__Baird for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.00
03.01.24
03.01.24
€75.98
03.01.25
03.01.25
-0.78%
18:54
18:54